Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE issues draft guidance rejecting Abbvie's Venclyxto in chronic lymphocytic leukaemia

pharmafileOctober 31, 2018

Tag: Abbvie's Venclyxto , leukaemia , CLL

PharmaSources Customer Service